Cargando…

A marker for hypoxic cells in tumours with potential clinical applicability.

Detalles Bibliográficos
Autores principales:	Chapman, J. D., Franko, A. J., Sharplin, J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1981
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010627/ https://www.ncbi.nlm.nih.gov/pubmed/7236492

Ejemplares similares

Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours.
por: Raleigh, J. A., et al.
Publicado: (1987)

Binding of 14C-misonidazole to hypoxic cells in V79 spheroids.
por: Franko, A. J., et al.
Publicado: (1982)

Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours.
por: Cline, J. M., et al.
Publicado: (1990)

Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells.
por: Parliament, M. B., et al.
Publicado: (1992)

Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo.
por: Webster, L., et al.
Publicado: (1998)

The hypoxic tumour microenvironment
por: Petrova, Varvara, et al.
Publicado: (2018)

A lineage-tracing tool to map the fate of hypoxic tumour cells
por: Vermeer, Jenny A. F., et al.
Publicado: (2020)

A dual hypoxic marker technique for measuring oxygenation change within individual tumors.
por: Iyer, R. V., et al.
Publicado: (1998)

Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
por: Brown, J. M., et al.
Publicado: (1979)

Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cells.
por: Foster, J. L., et al.
Publicado: (1976)

Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.
por: Raleigh, J. A., et al.
Publicado: (1985)

Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour.
por: Stanley, J. A., et al.
Publicado: (1977)

Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection.
por: Hodgkiss, R. J., et al.
Publicado: (1991)

Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers
por: Chan, K C A, et al.
Publicado: (2007)

Hypoxic Signalling in Tumour Stroma
por: Laitala, Anu, et al.
Publicado: (2018)

Targeting hypoxic tumour cells to overcome metastasis
por: Bennewith, Kevin L, et al.
Publicado: (2011)

Interaction of hyperthermia and the hypoxic cell sensitizer Ro-07-0582 on the EMT6 mouse tumour.
por: Bleehen, N. M., et al.
Publicado: (1977)

Porphyrins and Metalloporphyrins: Potential Hypoxic Agents
por: James, B. R., et al.
Publicado: (1996)

Targeting radiation-resistant hypoxic tumour cells through ATR inhibition
por: Pires, I M, et al.
Publicado: (2012)

GLUT1 gene is a potential hypoxic marker in colorectal cancer patients
por: Chung, Fu-Yen, et al.
Publicado: (2009)

Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy.
por: van Geel, I. P., et al.
Publicado: (1996)

A serum factor with potential as a tumour marker in malignant lymphoma.
por: Begent, R. H., et al.
Publicado: (1980)

Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours
por: Hiley, Crispin T, et al.
Publicado: (2009)

A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.
por: Abratt, R. P.
Publicado: (1982)

CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target
por: Drenckhan, Astrid, et al.
Publicado: (2018)

The effect of an hypoxic cell sensitizer on tumour growth delay and cell survival. Implications for cell survival in situ and in vitro.
por: McNally, N. J.
Publicado: (1975)

Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations
por: Pinato, D J, et al.
Publicado: (2013)

Inside the hypoxic tumour: reprogramming of the DDR and radioresistance
por: Begg, Katheryn, et al.
Publicado: (2020)

Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice.
por: Sheldon, P. W., et al.
Publicado: (1977)

Tumour markers in breast cancer.
por: Cove, D. H., et al.
Publicado: (1979)

Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990)

The tumour microenvironment links complement system dysregulation and hypoxic signalling
por: Olcina, Monica M, et al.
Publicado: (2019)

Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell lines
por: Stewart, G D, et al.
Publicado: (2008)

Metabolic profiling reveals potential metabolic markers associated with Hypoxia Inducible Factor-mediated signalling in hypoxic cancer cells
por: Armitage, Emily G., et al.
Publicado: (2015)

Non-coding RNAs predict recurrence-free survival of patients with hypoxic tumours
por: Martinez, Victor D., et al.
Publicado: (2018)

Hydroethidine: a fluorescent redox probe for locating hypoxic cells in spheroids and murine tumours.
por: Olive, P. L.
Publicado: (1989)

Kill-painting of hypoxic tumours in charged particle therapy
por: Tinganelli, Walter, et al.
Publicado: (2015)

Divergent mutational processes distinguish hypoxic and normoxic tumours
por: Bhandari, Vinayak, et al.
Publicado: (2020)

Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour.
por: Hill, S. A., et al.
Publicado: (1977)

Reducing the hypoxic fraction of a tumour model by growth in low glucose.
por: Hlatky, L., et al.
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_boi0m78sucagpg3tt6093huc5n